YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Effect of $18{\beta}$-Glycyrrhetinic Acid on Septic Arthritis Caused by Candida albicans

$18{\beta}$-Glycyrrhetinic Acid의 항 감염성관절염효과

  • 한용문 (동덕여자대학교 약학대학 면역 미생물학교실)
  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

A polymorphic fungus, Candida albicans, causes various forms of infections such as disseminated candidiasis and vaginitis. Recent reports indicate that the fungus is a main etiological agent for the arthritis. In search of new sources for treatment of the fungal arthritis, we examined $18{\beta}$-glycyrrhetinic acid ($18{\beta}$-GA) against C. albicans-caused septic arthritis. The compound is isolated from Glycyrrhizae Radix that is known to have various immunomodulating activities and is one of the most popular herbal medicines. For induction of animal model of a septic arthritis, mice were given an emulsion form of C. albicans cell wall mixed with Complete Freund's Adjuvant (CFA) via footpad-injection. To determine prophylactic and therapeutic effects, the component was given to the animals before or after the induction of the arthritis, respectively. Data showed that intraperitoneal administration of $18{\beta}$-GA resulted in reduction of the inflammation, indicating the component had both prophylactic and therapeutic activities. For investigation of mechanism of the $18{\beta}$-GA, inhibitory effects on NO (nitiric oxide) and on T-lymphocyte proliferation were determined. Results demonstrated that $18{\beta}$-GA suppressed NO production from LPS (lipopolysaccharide)-treated macrophages and also inhibited proliferation of Con A (concanavalin A)activated T-cells. Taken together, $18{\beta}$-GA, a pentacyclic triterpene, has anti-arthritic activity against C. albicans-caused septic arthritis, possibly by blocking NO production and T-cell suppression.

Keywords

References

  1. Han, Y. : Ginkgo terpene component has an anti-inflammatory effect on Candida albicans-caused arthritis. Int. Immuno-pharmacol. 5, 1049 (2005) https://doi.org/10.1016/j.intimp.2005.02.002
  2. Lee, S. and Han, Y. : Isolation and analysis of ginkgolides compound from EGb 761. Dongduk Pharm. Res. 7, 39 (2003)
  3. Cuende, E., Barbadillo, C. E., Mazzucchelli, R., Isasi, C, Trujillo, A. and Andreu, J. L. : Candida arthritis in adult patients who are not intravenous drug addicts: report of three cases and review of the literature. Semin Arthritis Rheum. 22, 224 (1993)
  4. Lerch, K., Kalteis, T., Schubert, T., Lehn, N. and Grifka, J. : Prosthetic joint infection with osteomyelitis due to Candida albicans. Mycoses. 46, 462 (2003) https://doi.org/10.1046/j.0933-7407.2003.00928.x
  5. Azaceta, G., Olave. X, de los Martires, L. D., Delgado, C, Gutierrez, M. and Palomera, L. : Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient. Rev. Rhum. Engl. 66, 434 (1999)
  6. Choi, I. S., Kim, S. J., Kim, B. Y., Joh, J. W., Kim, Y. I., Lee, S. K., Huh, W. S., Oh, H. Y., Kim, D. J., Kim, Y. G., Kim, M. K., Ko, Y. H. and Lee, B. B. : Candida polyarthritis in a renal transplant patient: case report of a patient successfully treated with amphotericin B. Transplant Proc. 32, 1963 (2000)
  7. Lee, D. M. and Weinblatt, M. E.: Rheumatoid arthritis. Lancrt. 358, 903 (2001) https://doi.org/10.1016/S0140-6736(00)05272-7
  8. Felson, D. T., Anderson, J. J. and Meena, R. E : Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis: a metaanalysis of published clinical trials. Arthritis Rheum. 35, 1117 (1992)
  9. Bauer, H. and Marker-Hermann, E. : Therapy with nonsteroidal anti-inflammatory drugs. Orthopade. 32, 1088 (2003) https://doi.org/10.1007/s00132-003-0559-2
  10. Ukil, A., Biswas, A., Das, T. and Das, R K.: 18|3-glycyrrhetinic acid triggers curative Thl response and nitiric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kB. J. Immunol. 175, 1161 (2005) https://doi.org/10.4049/jimmunol.175.2.1161
  11. Carlo, E, Mario, R and Giogio, R : Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids. FARMACO 53, 22 (1998)
  12. Jeong, H. G., You, H., Park, S. J., Moon, A. R., Chung, Y. C, Kang, S. K. and Chun, H. K. : Hepatoprotective effects of 18$\beta$-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2EI expression. Pharmacol. Res. 46, 221 (2002)
  13. Berg, A. J., Wolbink, G. J. van Dijk, H. and Labadie, R. R : Inhibition of human complement by glycyrrhetinic acid. Immunology 90, 115 (1997)
  14. Kinne, R. W., Brauer, R., Stuhlmuller, B., Palombo-kinne, E. and Burmester, G.-R. : Macrophages in rheumatoid arthritis. Arthritis Res. 2, 189 (2000)
  15. Nissler, K., Pohlers, D., Huckel, M., Simon, J., Brauer, R. and Kinne, R. W. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann. Rheum. Dis. 63, 1470 (2004) https://doi.org/10.1136/ard.2003.013060
  16. Paniagua, R. T., Sharpe, O., Ho, R R, Chan, S. M., Chang, A., Higgins, J. R, Tomooka, B. H., Thomas, E M., Song, J. J., Goodman, S. B., Lee, D. M., Genovese, M. C, Utz, R J., Steinman, L. and Robinson, W. H. : Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J. Clin. Invest. 116, 2633 (2006) https://doi.org/10.1172/JCI28546.
  17. Colic, M., Vucevic, D., Kilibarda, V, Radicevic, N. and Savic, M. : Modulatory effects of garlic extracts on proliferation of T-lymphocytes in vitro stimulated with concanavalin A. Phytomedicine. 9, 117 (2002)
  18. Gao, X., Deeb, D., Media, J., Divine, G., Jiang, H., Chapman, R. A. and Gautam, S. C. : Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem. Pharmacol. 66, 2427 (2003) https://doi.org/10.1016/j.bcp.2003.08.008
  19. Ranjan, D., Chen, C, Johnston, T. D., Jeon, H. and Nagabhushan, M. : Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J. Surg. Res. 121, 171 (2004) https://doi.org/10.1016/j.jss.2004.04.004
  20. Han, Y. and Cutler, J. E. : Antibody response that protects against disseminated candidiasis. Infect. Immun. 63, 2714 (1995)
  21. Han, Y, Kozel, T. R., Zhang, M. X., MacGill, R. S., Carroll, M. C. and Cutler, J. E.: Complement is essential for protection by an lgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis. J. Immunol. 167, 1550 (2001) https://doi.org/10.4049/jimmunol.167.1.1
  22. Han, Y, Ulrich, M. A. and Cutler, J. E. : Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. 179, 1477 (1999)
  23. Lotito, A. E, Muscara, M. N., Kiss, M. H., Teixeira, S. A., Novaes, G. S., Laurindo, I. M., Silva, C. A. and Mello, S. B. : Nitric oxide-derived species in synovial fluid from patients with juvenile idiopathic arthritis. Rheumatol. 31, 992 (2004)
  24. Pohlers, D., Nissler, K., Frey, O., Simon, J., Petrow, P. K., Kinne, R. W. and Brauer, R. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin. Exp. Immunol. 135, 409 (2004) https://doi.org/10.1111/j.1365-2249.2003.02381.x
  25. Nissler, K., Pohlers, D., Hckel, M., Simon, J., Brauer, R. and Kinne, R. W. : Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann. Rheum. Dis. 63, 1470 (2004) https://doi.org/10.1136/ard.2003.013060